Table III.
N=32 | Stage 2 | Stage 1 | Total | |
---|---|---|---|---|
RO | 5 | 11 | 16 | P=0.0011 |
DE | 14 | 2 | 16 | OR=0.06 |
Total | 19 | 13 | 32 | 95% CI=0.01-0.40 |
N=133 | Stage 3 | Stage 2 | Total | |
RO | 81 | 5 | 86 | P=0.0001 |
DE | 33 | 14 | 47 | OR=6.87 |
Total | 114 | 19 | 133 | 95% CI=2.29-20.61 |
N=146 | Stage 3 | Stage 1+2 | Total | |
RO | 81 | 16 | 97 | P=0.026 |
DE | 33 | 16 | 49 | OR=2.45 |
Total | 114 | 32 | 146 | 95% CI=1.10-5.47 |
aRisk analyses starting from the assumption that the lack of information that exists in the Romanian system may be a risk factor regarding the development of new lethal diseases or a rapid increase from stage 1 to stage 3. DE, German patient group; RO, Romanian patient group. OR, odds ratio; CI, confidence interval.